CJC-1295 / Ipamorelin
SKU: BDL-IPA-010
Dosage:
$85.00 AUD
Compound Specifications
Research Notes
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) modified with a Drug Affinity Complex (DAC), a linker that binds to circulating albumin and extends its half-life substantially compared with native GHRH. Ipamorelin is a synthetic pentapeptide belonging to the growth hormone secretagogue class, acting through the ghrelin receptor (GHS-R1a).
The combination engages two complementary receptor systems in the somatotropic axis: CJC-1295 through the GHRH receptor and Ipamorelin through the ghrelin receptor. This dual-pathway approach has been examined in research settings for its synergistic amplification of growth hormone pulsatility.
The pairing is commonly used in research protocols investigating the growth hormone axis, combining a sustained elevation of GH-releasing capacity with discrete high-amplitude pulses.
Supply & Quality
All products are research compounds intended for laboratory research use only. Not for human or veterinary use. Kinetic Labs does not provide dosing guidance, therapeutic recommendations, or medical advice of any kind.